BTK-IN-44
BTK-IN-44 (Compound 10) is a potent noncovalent inhibitor of Bruton’s tyrosine kinase (BTK) with an IC50 value of 24.7 nM. BTK-IN-44 interferes with signaling pathways of B cell malignancies, showing antitumor effects in lymphoma cells. BTK-IN-44 is promising for research of B cell malignancies (such as lymphoma) [1].
Product Specifications
UNSPSC
12352005
Target
Btk
Related Pathways
Protein Tyrosine Kinase/RTK
Field of Research
Cancer
Smiles
CC1=C(NC(C2=CC3=C(C=CC=C3)N2)=O)C=CC=C1C4=CC=C5C(NC6=CC(C(O)(C)C)=CC=C6N54)=O
Molecular Formula
C30H26N4O3
Molecular Weight
490.55
References & Citations
[1]Tian C, et al. Structure-based design of novel pyrrolo[1,2-a]quinoxalin-4 (5H) -one derivatives as potent noncovalent Bruton's tyrosine kinase (BTK) inhibitors. Bioorg Med Chem Lett. 2025 Sep 1;125-126:130285.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS645701-01 0.2 mL
hCG_2039146, ID (SHISA7, Protein shisa-7, Protein shisa-6-like)
Ask
View Details MBS645701-02 5x 0.2 mL
hCG_2039146, ID (SHISA7, Protein shisa-7, Protein shisa-6-like)
Ask
View Details GTR15289030 1 Vial
Lentiviral mouse Tll2 shRNA (UAS) - Lentiviral mouse Tll2 shRNA (UAS, GFP) plasmid
Ask
View Details